ZIDOVAL

This brand name is authorized in Finland, Israel, Malta, UK.

Active ingredients

The drug ZIDOVAL contains one active pharmaceutical ingredient (API):

1
UNII 140QMO216E - METRONIDAZOLE
 

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

 
Read more about Methronidazole

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ZIDOVAL Vaginal gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G01AF01 Metronidazole G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FI Lääkealan turvallisuus- ja kehittämiskeskus 002193
GB Medicines & Healthcare Products Regulatory Agency 191754
IL מִשְׂרַד הַבְּרִיאוּת 4211
MT Medicines Authority AA1187/03601

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.